Abstract
The emergence of the covid-19 disease pandemic caused by the 2019 novel coronavirus has required a re-evaluation of treatment practices for clinicians caring for patients with chronic lymphocytic leukemia (cll). The American Society for Hematology (ash) has provided a series of recommendations for the treatment of patients with cll during the pandemic, covering a range of topics, including testing for covid-19, cll treatment initiation and selection, use of immunoglobulin therapy, in-person monitoring, and treatment of patients with cll and covid-19. We summarize the ash recommendations and discuss their applicability as guidelines for the treatment of cll during the covid-19 pandemic in Canada.
Highlights
Patients with chronic lymphocytic leukemia present a unique set of challenges for treating clinicians
The American Society for Hematology has provided a series of recommendations for the treatment of patients with cll during the time of the pandemic, which are available at ht t ps ://w w w.hematolog y.org/cov id-19/cov id-19-a nd-cl l (“COVID-19 and CLL: Frequently Asked Questions”)[8]
We summarize the ash recommendations and discuss their applicability as guidelines for the treatment of cll during covid-19 in Canada
Summary
Patients with chronic lymphocytic leukemia (cll) present a unique set of challenges for treating clinicians. Given the increased risk of infection in the cll population and the associated morbidity and mortality, it is important to ensure that patients with cll are protected, while still being optimally treated during the covid-19 outbreak. The American Society for Hematology (ash) has provided a series of recommendations for the treatment of patients with cll (with or without the covid-19 infection) during the time of the pandemic, which are available at ht t ps ://w w w.hematolog y.org/cov id-19/cov id-19-a nd-cl l (“COVID-19 and CLL: Frequently Asked Questions”)[8].
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
